| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 283,455 | 285,230 | 260,594 | 251,142 | | Cost of Revenue | 124,547 | 138,835 | 111,538 | 109,007 | | | Gross Profit | 158,908 | 146,395 | 149,056 | 142,135 | | | Operating Expenses | | Research Development | 8,266 | 7,737 | 10,063 | 7,232 | | Selling General and Administrative | 102,858 | 100,038 | 93,705 | 94,992 | | Non Recurring | 471 | 462 |
-
| 2,954 | | Others | 5,370 | 4,233 | 4,080 | 4,177 | | | | Total Operating Expenses | 116,965 | 112,470 |
-
| 109,355 | | | | Operating Income or Loss | 41,943 | 33,925 | 41,208 | 32,780 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 866 | (155) | 259 | 8,145 | | Earnings Before Interest And Taxes | 42,809 | 33,770 | 41,467 | 40,925 | | Interest Expense | 10,771 | 11,085 | 10,830 | 11,457 | | Income Before Tax | 32,038 | 22,685 | 30,637 | 29,468 | | Income Tax Expense | 1,920 | 777 | 5,988 | 5,595 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,118 | 21,908 | 24,649 | 23,873 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,118 | 21,908 | 24,649 | 23,873 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,118 | $21,908 | $24,649 | $23,873 |
|
0.51% Nasdaq 0.00%
Income Statement
